Tepotinib for treating advanced non-small-cell lung cancer with MET gene alterations

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 8.96 MB)

  Published:

  18 May 2022

• Final appraisal determination committee papers (PDF 3.11 MB)

  Published:

  18 May 2022